Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
Click Therapeutics has raised $50.0M in total funding. The most recent round was Series D. The last funding was announced in April 2026.
Click Therapeutics's investors include Revelation Partners, Boehringer Ingelheim, Sanofi Ventures, Accelmed, Silicon Valley Bank.
Click Therapeutics is headquartered in New York, United States.
Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
Click Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Click Therapeutics — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/click-therapeutics. Accessed October 30, 2026.
VCBacked. (2026). Click Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/click-therapeutics
{{cite web |title=Click Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/click-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated